Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults

Annals of the New York Academy of Sciences

Volumn 958, Issue , 2002, Pages 99-106

  Falorni, Alberto ^a,b   Calcinaro, Filippo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Dipto Med Int Sci Endocr M   (Italy)

Author keywords

Autoimmune polyglandular syndrome; Autoimmunity; Insulin therapy; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; ORAL ANTIDIABETIC AGENT;

ADDISON DISEASE; ADULT; AGED; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; HASHIMOTO DISEASE; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENCE; LATENT AUTOIMMUNE DIABETES IN ADULTS; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL;

EID: 0036271280     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02951.x     Document Type: Conference Paper

References (30)

1. Immunology of insulin-dependent diabetes mellitus
2. Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
3. Humoral and cellular immune response to insulin
4. Controversies on humoral immune markers of insulin-dependent diabetes mellitus
5. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA-DQA1*0301-DQB1*0302 haplotype at clinical onset of type I (insulin-dependent) diabetes before age 10 years but not at onset between age 10 and 40 years. The Belgian diabetes registry
6. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian diabetes registry
7. Immunological heterogeneity in type I diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive diseases
8. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes mellitus
9. Two distinct MICA gene markers discriminate major autoimmune diabetes types
10. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type
11. Islet cell antibodies identify latent type I diabetes in patients aged 37-75 years at diagnosis
12. β-cell function in relation to islet cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients
13. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type
14. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
15. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
16. GAD antibodies in NIDDM
17. Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese
18. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
19. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
20. Insulin secretion and insulin sensitivity in diabetic subgroups: Studies in the prediabetic and diabetic state
21. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus
22. Increased risk for endocrine autoimmunity in type 2 diabetic patients with GAD65 autoantibodies
23. Sex differences in incidence of IDDM in age-group 15-29 years. Higher risk in males in Province of Turin, Italy
24. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy
25. Screening for thyroid disease in children with IDDM
26. Thyroid autoimmunity in insulin-dependent diabetes mellitus: The case for routine screening
27. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. The Belgian diabetes registry
28. IDDM and autoimmune thyroid disease in the pediatric age group
29. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency
30. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease